CIBC Asset Management Inc Buys 3,342 Shares of Avantor, Inc. (NYSE:AVTR)

CIBC Asset Management Inc lifted its stake in Avantor, Inc. (NYSE:AVTR) by 13.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,507 shares of the company’s stock after buying an additional 3,342 shares during the period. CIBC Asset Management Inc’s holdings in Avantor were worth $580,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio lifted its stake in Avantor by 34.1% during the third quarter. Public Employees Retirement System of Ohio now owns 346,822 shares of the company’s stock worth $8,972,000 after purchasing an additional 88,205 shares during the last quarter. Perpetual Ltd lifted its stake in Avantor by 38.7% during the fourth quarter. Perpetual Ltd now owns 1,766,882 shares of the company’s stock worth $37,228,000 after purchasing an additional 493,408 shares during the last quarter. New York State Teachers Retirement System bought a new stake in Avantor during the third quarter worth $8,473,000. Everence Capital Management Inc. bought a new stake in Avantor during the fourth quarter worth $555,000. Finally, Rhumbline Advisers lifted its stake in Avantor by 1.8% during the fourth quarter. Rhumbline Advisers now owns 1,922,368 shares of the company’s stock worth $40,504,000 after purchasing an additional 33,692 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.

Avantor Stock Performance

NYSE AVTR opened at $17.31 on Friday. The company has a market capitalization of $11.78 billion, a price-to-earnings ratio of 16.64, a PEG ratio of 1.57 and a beta of 1.28. Avantor, Inc. has a twelve month low of $17.14 and a twelve month high of $28.00. The stock has a fifty day simple moving average of $20.96 and a 200 day simple moving average of $22.94. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the prior year, the business earned $0.22 earnings per share. Sell-side analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Analyst Upgrades and Downgrades

AVTR has been the subject of several recent analyst reports. Stifel Nicolaus cut their target price on Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a research note on Monday, February 10th. Royal Bank of Canada dropped their price target on Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research note on Monday, February 10th. Wells Fargo & Company dropped their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Raymond James reiterated an “outperform” rating and issued a $24.00 price target (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Finally, Barclays dropped their price target on Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $25.92.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.